LH - Laboratory Corporation of America Holdings

NYSE - NYSE Delayed Price. Currency in USD

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336-229-1127
http://www.labcorp.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees60,000

Key Executives

NameTitlePayExercisedYear Born
Mr. David P. KingChairman, CEO & Pres3.07M11.36M1956
Mr. Glenn A. EisenbergCFO & Exec. VP1.34MN/A1961
Mr. Lance V. BerberianChief Information Officer & Sr. VP612.04kN/A1963
Mr. F. Samuel Eberts IIIChief Legal Officer, Chief Compliance Officer, Sr. VP & Sec.803.3kN/A1960
Ms. Lisa J. UthgenanntChief HR Officer & Sr. VP770.85kN/A1961
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually-transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. The company also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, medical drug monitoring, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides drug development solutions and laboratory testing services; and testing services through a sales force to the managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

Corporate Governance

Laboratory Corporation of America Holdings’s ISS Governance QualityScore as of April 1, 2018 is 1. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.